Rohit Chopra

AAFD To Honor Sen Catherine Cortez Masto, FTC Commissioner Rohit Chopra and CA Department of Financial Protection & Innovation for Service to the Franchising Community

Retrieved on: 
Wednesday, June 23, 2021

Honorees include United States Senator Catherine Cortez Masto (D-NV), Federal Trade Commission Commissioner Rohit Chopra, and the California Department of Financial Protection and Innovation (DFPI).

Key Points: 
  • Honorees include United States Senator Catherine Cortez Masto (D-NV), Federal Trade Commission Commissioner Rohit Chopra, and the California Department of Financial Protection and Innovation (DFPI).
  • The tributes will be presented at the AAFD's TQF Awards ceremony on June 24th during the AAFD's annual Franchisee Leadership Summit.
  • She has been instrumental in demanding oversight to protect franchisees, including introducing legislation to provide greater oversight and transparency from the Small Business Administration (SBA).
  • Federal Trade Commission Commissioner Rohit Chopra is the first commissioner in decades to draw attention to the franchise industry.

Hoffa: Chopra Will Be An Active Watchdog Overseeing Nation's Financial Sector

Retrieved on: 
Monday, January 18, 2021

"The federal government has been asleep at the wheel when it comes to oversight of the financial markets during the past four years.

Key Points: 
  • "The federal government has been asleep at the wheel when it comes to oversight of the financial markets during the past four years.
  • President-elect Biden knows this, which is why he made the excellent choice of Rohit Chopra to head up the CFPB in his administration.
  • "Chopra is no stranger to the agency, as he served as an assistant director during the Obama administration.
  • The Teamsters look forward to working with Chopra to create a fairer financial marketplace for workers."

FTC Approves Final Administrative Consent Order with Marketer of Product Falsely Claiming to Prevent or Treat COVID-19

Retrieved on: 
Monday, October 19, 2020

The complaint also alleged that Ching used his Whole Leaf Organics website to deceptively advertise and sell three CBD-containing products.

Key Points: 
  • The complaint also alleged that Ching used his Whole Leaf Organics website to deceptively advertise and sell three CBD-containing products.
  • He also must tell customers and retailers that the three CBD-containing products will not treat cancer.
  • Finally, the letters must inform customers and retailers of his settlement with the FTC.
  • The Commission vote approving the final consent order and letter to one public commenter was 3-1-1, with Commissioner Rohit Chopra dissenting and Commissioner Rebecca Slaughter not participating.

FTC Approves Final Administrative Consent Order with Marketer of Product Falsely Claiming to Prevent or Treat COVID-19

Retrieved on: 
Monday, October 19, 2020

The complaint also alleged that Ching used his Whole Leaf Organics website to deceptively advertise and sell three CBD-containing products.

Key Points: 
  • The complaint also alleged that Ching used his Whole Leaf Organics website to deceptively advertise and sell three CBD-containing products.
  • He also must tell customers and retailers that the three CBD-containing products will not treat cancer.
  • Finally, the letters must inform customers and retailers of his settlement with the FTC.
  • The Commission vote approving the final consent order and letter to one public commenter was 3-1-1, with Commissioner Rohit Chopra dissenting and Commissioner Rebecca Slaughter not participating.

FTC Approves Final Order Imposing Conditions on AbbVie Inc.’s Acquisition of Allergan plc

Retrieved on: 
Friday, September 4, 2020

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that AbbVies $63 billion acquisition of Allergan would violate federal antitrust law.

Key Points: 
  • Following a public comment period, the Federal Trade Commission has approved a final order settling charges that AbbVies $63 billion acquisition of Allergan would violate federal antitrust law.
  • The final order requires AbbVie and Allergan to divest to Nestl, S.A. Allergans Zenpep and Viokase, which are currently sold to treat EPI.
  • AbbVie and Allergan also are required to divest to AstraZeneca plc.
  • The Commission vote to approve the final order was 3-1-1, with Commissioner Rohit Chopra voting no and Commissioner Rebecca Kelly Slaughter not participating.

FTC Approves Final Order Imposing Conditions on AbbVie Inc.’s Acquisition of Allergan plc

Retrieved on: 
Friday, September 4, 2020

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that AbbVies $63 billion acquisition of Allergan would violate federal antitrust law.

Key Points: 
  • Following a public comment period, the Federal Trade Commission has approved a final order settling charges that AbbVies $63 billion acquisition of Allergan would violate federal antitrust law.
  • The final order requires AbbVie and Allergan to divest to Nestl, S.A. Allergans Zenpep and Viokase, which are currently sold to treat EPI.
  • AbbVie and Allergan also are required to divest to AstraZeneca plc.
  • The Commission vote to approve the final order was 3-1-1, with Commissioner Rohit Chopra voting no and Commissioner Rebecca Kelly Slaughter not participating.

FTC Approves Final Order Settling Charges that Danaher Corporation’s Acquisition of GE Biopharma Was Anticompetitive

Retrieved on: 
Friday, May 29, 2020

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Danaher Corporations acquisition of GE Biopharmawould likely reduce competition in highly concentrated markets that supply biopharmaceutical companies with key inputs.

Key Points: 
  • Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Danaher Corporations acquisition of GE Biopharmawould likely reduce competition in highly concentrated markets that supply biopharmaceutical companies with key inputs.
  • Danaher is divesting to Sartorius AG all rights and assets to research, develop, manufacture, market, and sell these products.
  • The Commission vote to approve the final order was 3-1-1, with Commissioner Rohit Chopra voting no and Commissioner Rebecca Kelly Slaughter not participating.
  • Like the FTC on Facebook, follow us on Twitter, read our blogs, and subscribe to press releases for the latest FTC news and resources.

FTC Approves Final Order Settling Charges that Danaher Corporation’s Acquisition of GE Biopharma Was Anticompetitive

Retrieved on: 
Friday, May 29, 2020

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Danaher Corporations acquisition of GE Biopharmawould likely reduce competition in highly concentrated markets that supply biopharmaceutical companies with key inputs.

Key Points: 
  • Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Danaher Corporations acquisition of GE Biopharmawould likely reduce competition in highly concentrated markets that supply biopharmaceutical companies with key inputs.
  • Danaher is divesting to Sartorius AG all rights and assets to research, develop, manufacture, market, and sell these products.
  • The Commission vote to approve the final order was 3-1-1, with Commissioner Rohit Chopra voting no and Commissioner Rebecca Kelly Slaughter not participating.
  • Like the FTC on Facebook, follow us on Twitter, read our blogs, and subscribe to press releases for the latest FTC news and resources.

FTC to Host Strictly Business: A Forum on Small Business Financing

Retrieved on: 
Tuesday, May 7, 2019

The forum will feature opening remarks by FTC Commissioner Rohit Chopra and closing remarks by FTC Bureau of Consumer Protection Director Andrew Smith, as well as a distinguished set of panelists .

Key Points: 

The forum will feature opening remarks by FTC Commissioner Rohit Chopra and closing remarks by FTC Bureau of Consumer Protection Director Andrew Smith, as well as a distinguished set of panelists .
The event will be webcast. The webcast link will be on the event page on the day of the workshop.

FTC to Host Strictly Business: A Forum on Small Business Financing

Retrieved on: 
Tuesday, May 7, 2019

The forum will feature opening remarks by FTC Commissioner Rohit Chopra and closing remarks by FTC Bureau of Consumer Protection Director Andrew Smith, as well as a distinguished set of panelists .

Key Points: 

The forum will feature opening remarks by FTC Commissioner Rohit Chopra and closing remarks by FTC Bureau of Consumer Protection Director Andrew Smith, as well as a distinguished set of panelists .
The event will be webcast. The webcast link will be on the event page on the day of the workshop.